Showing results (31-40 of 125) with videos related to

Sort By:
Pageof 13
Experimental Biology and Medicine (Maywood, N.J.)|March 8, 2011
Targeting transforming growth factor βRII expression inhibits the activation of hepatic stellate cells and reduces collagen synthesisRongquan Fu, Jinguo Wu, Jiguang Ding, et al.
Frontiers in Medicine|December 3, 2021
Proton Pump Inhibitor Therapy Does Not Affect Prognosis of Cirrhosis Patients With Acute Decompensation and Acute-on-Chronic Liver Failure: A Single-Center Prospective StudyShanshan Sun, Wenyi Ye, Ruihong Zhao, et al.
Annals of Hepatology|November 23, 2022
Hepatitis E virus superinfection impairs long-term outcome in hospitalized patients with hepatitis B virus-related decompensated liver cirrhosisHong Zhao, Wenyi Ye, Xia Yu, et al.
Annals of Translational Medicine|July 4, 2020
Coronavirus disease 2019 (COVID-19): chest CT characteristics benefit to early disease recognition and patient classification-a single center experienceHua Zhou, Kaijin Xu, Yihong Shen, et al.
BMC Gastroenterology|August 27, 2024
A dynamic model to predict early occurrence of acute kidney injury in ICU hospitalized cirrhotic patients: a MIMIC database analysisHuilan Tu, Junwei Su, Kai Gong, et al.
Aging|November 23, 2020
Impact of age on duration of viral RNA shedding in patients with COVID-19Chenliang Zhou, Tianfang Zhang, Haotang Ren, et al.
Chemotherapy|October 26, 2011
Efficacy of CG(3)R(6)TAT nanoparticles self-assembled from a novel antimicrobial peptide for the treatment of Candida albicans meningitis in rabbitsKaijin Xu, Huaying Wang, Lihong Liu, et al.
The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Medicale|October 25, 2021
Predictors of COVID-19 Infection: A Prevalence Study of Hospitalized PatientsHuilan Tu, Hong Zhao, Junwei Su, et al.
Infection|February 9, 2019
Antagonistic effect between tigecycline and meropenem: successful management of KPC-producing Klebsiella pneumoniae infectionSheng Bi, Xin Yao, Cheng Huang, et al.
Journal of Hepatology|June 11, 2014
Switching from entecavir to PegIFN alfa-2a in patients with HBeAg-positive chronic hepatitis B: a randomised open-label trial (OSST trial)Qin Ning, Meifang Han, Yongtao Sun, et al.
Pageof 13